Skip to main content
Equibles
TARS $69.20 +0.46%
TARS logo

TARS · Tarsus Pharmaceuticals, Inc.

Track TARS — free

Use TARS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TARS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$69.20 +0.32 (+0.46%) At close · Aug 14
Market Cap
$3.04B
Shares
43.88M
All earnings calls

Earnings call · FY2023 Q1

Tarsus Pharmaceuticals, Inc. Q1 FY2023 Earnings Call

Tarsus Pharmaceuticals, Inc. Q1 FY2023 Earnings Call

Concluded May 9, 2023
May 9, 2023 0 turns
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $2.50M +363.8% YoY
Diluted EPS -$0.88
Net income -$23.42M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 9, 2023 10-Q report Filed May 9, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License and Collaboration$2.50M +363.8% YoY
License and Collaboration Other$0
Product$0
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)